BioStem Tech
BSEM1.6802.44% ( +0.040 )
BioStem Tech (BSEM)
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenera...
- Open
- 1.620
- High
- 1.780
- Low
- 1.550
- Prev. Close
- 1.640
- Volume
- 197.23K
- Turnover
- 328.76K
- Avg Price
- 1.667
- Bid/Ask Ratio
- --
- Amplitude
- 14.02%
- 52wk High
- 5.440
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.39%
- 52wk Low
- 1.450
- Float Mkt Cap
- 23.84M
- Market CapUSD
- 31.22M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.52
- EPSDynamic
- -1.91
- EPSStatic
- --
- BVPS
- 1.49
- P/B
- 1.13
- Circulating Supply
- 14.19M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 18.58M
- Min lot size
- 1
- Currency
- USD
BioStem Tech Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$7.00316.67%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report ·
Selective Institutional Bets Emerge in Medical and Tech Niches
- PUBT ·
BioStem wins US patent for sterile human placental allografts, methods of making them
- TradingView ·
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants
- PUBT ·
BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rules
